These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1524428)

  • 61. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
    Murayama N; Soyama A; Saito Y; Nakajima Y; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kimura H; Goto Y; Saitoh O; Katoh M; Ohnuma T; Kawai M; Sugai K; Ohtsuki T; Suzuki C; Minami N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):300-6. PubMed ID: 14563787
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Purification and reconstitution of activity of Saccharomyces cerevisiae P450 61, a sterol delta 22-desaturase.
    Kelly SL; Lamb DC; Corran AJ; Baldwin BC; Parks LW; Kelly DE
    FEBS Lett; 1995 Dec; 377(2):217-20. PubMed ID: 8543054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nitrogenous ligation at the sixth coordination position of the Thr-301 to Lys-mutated P450IIC2 heme iron.
    Imai Y; Nakamura M
    J Biochem; 1991 Dec; 110(6):884-8. PubMed ID: 1794978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
    Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D
    Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ligand binding studies of engineered cytochrome P-450d wild type, proximal mutants, and distal mutants.
    Shimizu T; Sadeque AJ; Sadeque GN; Hatano M; Fujii-Kuriyama Y
    Biochemistry; 1991 Feb; 30(6):1490-6. PubMed ID: 1993167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2000 Sep; 39(37):11319-29. PubMed ID: 10985777
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
    Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Substitutions in the C-terminal portion of the catalytic domain partially reverse assembly defects introduced by mutations in the N-terminal linker sequence of cytochrome P450 2C2.
    Doray B; Chen CD; Kemper B
    Biochemistry; 1999 Sep; 38(37):12180-6. PubMed ID: 10508423
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of Glu318 at the putative distal site in the catalytic function of cytochrome P450d.
    Ishigooka M; Shimizu T; Hiroya K; Hatano M
    Biochemistry; 1992 Feb; 31(5):1528-31. PubMed ID: 1346571
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stabilization of P450 2B4 by its association with P450 1A2 revealed by high-pressure spectroscopy.
    Davydov DR; Petushkova NA; Archakov AI; Hoa GH
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1005-12. PubMed ID: 11027582
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
    Chang TK; Chen J; Benetton SA
    Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of different solubilizing agents on the aggregation state and catalytic activity of two purified rabbit cytochrome P450 isozymes, CYP1A2 (LM4) and CYP2B4 (LM2).
    Viner RI; Novikov KN; Ritov VB; Kagan VE; Alterman MA
    Biochem Biophys Res Commun; 1995 Dec; 217(3):886-91. PubMed ID: 8554612
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2.
    Kelley RW; Reed JR; Backes WL
    Biochemistry; 2005 Feb; 44(7):2632-41. PubMed ID: 15709776
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
    Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
    Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.
    Lewis BC; Mackenzie PI; Miners JO
    Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interaction of Angeli's salt with cytochrome P450 1A2 distal mutants: an optical absorption spectral study.
    Shibata Y; Sato H; Sagami I; Shimizu T
    Biochim Biophys Acta; 1997 Nov; 1343(1):67-75. PubMed ID: 9428660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Marked detergents effects on safranine T-mediated photo-induced electron transfer in cytochrome P-450 1A2.
    Nakano R; Konami H; Sato H; Ito O; Shimizu T
    Biochim Biophys Acta; 1995 Oct; 1252(2):245-50. PubMed ID: 7578230
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase.
    Wen B; Lampe JN; Roberts AG; Atkins WM; David Rodrigues A; Nelson SD
    Arch Biochem Biophys; 2006 Oct; 454(1):42-54. PubMed ID: 16959210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.